Quantcast
Last updated on April 24, 2014 at 11:24 EDT

Latest Early-onset Alzheimer's disease Stories

2012-07-09 06:28:18

NEW YORK, July 9, 2012 /PRNewswire/ -- The Galien Foundation today announced the formal program of presenters and panels for its Third Galien Forum, scheduled for Tuesday, October 16, 2012 at the Alexandria Center for Life Science in New York City. The Galien Forum, conducted in conjunction with the prestigious Prix Galien Awards, features roundtable debates focusing on critical, global healthcare issues and challenges. This year's program includes a panel of CEO emeriti making rare public...

Possible Link Between Alzheimer's Disease And Diabetes
2012-06-15 10:39:25

Connie K. Ho for redOrbit.com W. H. Auden once said, “There is more than meets the idea.” This idea can be applied to many things, but certainly in the realm of health and science. Connections that my have not seemed likely beforehand may appear as viable links through research. In particular, scientists from City College of New York-City University of New York (CCNY-CUNY) recently published research that shows a connection between Alzheimer´s disease and diabetes. The...

2012-06-01 06:23:08

INDIANAPOLIS, June 1, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, today announced that Amyvid is available to imaging centers in markets surrounding 16 manufacturing sites located in Atlanta; Charlotte, N.C.; Chicago; Colton, Calif; Columbus, Ohio; Dallas; Fort Lauderdale, Fla.; Hartford, Conn.; Houston; Jacksonville, Fla.; North Wales, Pa.; Orlando, Fla.; Palo Alto, Calif.; Phoenix; Seattle; and...

2012-04-25 06:24:41

NEW ORLEANS, April 25, 2012 /PRNewswire/ -- Results of a phase III study that showed tremendous reliability in the detection of beta-amyloid in the living brain will be presented by Marwan Sabbagh, MD, director of Banner Sun Health Research Institute in Sun City Arizona. The presentation is part of the Emerging Science Program on April 25th at the American Academy of Neurology's 64th Annual meeting in New Orleans. Historically, Alzheimer's disease has only been definitively confirmed...

2012-04-04 09:25:27

Improvement shown in blood vessel function following drug treatment A cholesterol drug commonly prescribed to reduce cardiovascular disease risk restores blood vessel function in a mouse model of Alzheimer's disease, according to a study in the April 4 issue of The Journal of Neuroscience. The drug simvastatin (Zocor®) – which works by slowing cholesterol production – also improves learning and memory in adult, but not aged Alzheimer's model mice. The findings add to a...

2012-03-20 02:24:02

- Donors Respond to the Alzheimer's Association's Call for Funding to Accelerate Discovery - CHICAGO, March 20, 2012 /PRNewswire-USNewswire/ -- The Alzheimer's Association announced today the awarding of its largest ever research grant - nearly $4.2 million dollars over four years - to the Dominantly Inherited Alzheimer's Network-Therapeutic Trials Unit (DIAN-TTU), based at Washington University School of Medicine in St. Louis, to enable the program to move forward more quickly with...

2012-03-15 16:58:00

BARCELONA, Spain, March 15, 2012 /PRNewswire/ -- Grifols (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS), the world's third largest plasma product manufacturer and a pioneer in the research and development of therapeutic alternatives designed to contribute to both scientific and social development, has acquired 51% of the equity of Zaragoza-based company Araclon Biotech, ensuring the viability of its projects and the future of the company. (Logo:...

2012-03-13 08:00:00

NEW YORK, March 13, 2012 /PRNewswire/ -- The Alzheimer's Association, New York City Chapter will host a free community event, open to the public, featuring a panel of experts who will explore the role of genetics in Alzheimer's disease. Titled, "The Role of Genetics in Alzheimer's Disease: An Evolving Landscape," the event will take place on Wednesday, March 14, 2012 at 6:00 p.m. at The Times Center in midtown Manhattan and will be moderated by WCBS-TV Medical Reporter Dr. Max Gomez, who was...

2012-02-20 15:00:00

Early-onset Alzheimer´s disease also part of Compassionate Allowances program, explains Allsup Belleville, Ill. (PRWEB) February 20, 2012 The federal government plans to make $50 million available immediately for cutting-edge Alzheimer´s disease research, reflecting the urgency in combatting the disease and providing a reminder that those with early-onset Alzheimer´s disease now can benefit from fast-track evaluation for Social Security Disability Insurance (SSDI) benefits,...

2012-02-10 15:06:20

“In the last eight days, scientists have delivered a powerful one-two punch in the fight to defeat Alzheimer´s disease,” said Stacy Pagos Haller, President and CEO of the American Health Assistance Foundation (AHAF), a nonprofit that identifies and funds exceptionally high-impact research worldwide through its  Alzheimer´s Disease Research program. “We are excited about today´s announcement by Case Western University researchers that a cancer drug,...